深圳市杰恩创意设计股份有限公司 一、独立董事的基本情况 （一）独立董事工作履历、专业背景及兼职情况 梁波先生，1972 年 11 月出生，中国国籍，无境外永久居留权，本科学历。 曾任华为欧洲消费者 BG 人力资源部部长，华为公司行政管理部人力资源部部长， 华为消费者战略 MKT 部人力资源部部长，华为消费者党委书记、宿州市千镖堂 武学教育咨询有限公司监事、深圳市瑞丰光电子股份有限公司独立董事、深圳市 杰恩创意设计股份有限公司独立董事等。现任华为全球培训中心（华为大学）教 授，南方科技大学外聘老师，昆山丘钛微电子科技股份有限公司董事，深圳市三 诺声智联股份有限公司董事。 （二）独立性说明 在担任公司独立董事期间，本人未在公司担任除独立董事以外的任何职务， 也未在公司主要股东的公司担任任何职务，与公司以及主要股东之间不存在妨碍 本人进行独立客观判断的关系，亦不存在影响独立董事独立性的情况，符合《公 司法》《证券法》《深圳证券交易所创业板股票上市规则》《深圳证券交易所上 市公司自律监管指引第 2 号——创业板上市公司规范运作》《上市公司独立董事 2024年度独立董事述职报告（梁波） 公司董事会、各位股东及股东代表： ...

张华先生，1962 年 1 月出生，中国国籍，中共党员，无境外永久居留权，研 究生学历，哈尔滨工业大学电子物理与器件专业，工学硕士学位。曾任哈尔滨工 业大学科研处科员、科长（副）、处长（副）、校长助理，深圳国际技术创新研 究院院长，深圳航天科技创新研究院院长兼党委书记，深圳市第六届人大代表、 深圳市第七届南山区人大代表、深圳市南山区政协委员、深圳清鹏智能有限公司 执行董事、深圳市杰恩创意设计股份有限公司独立董事等。现任深圳市格灵精睿 视觉有限公司董事长，深圳烯创先进材料研究院有限公司董事长，深圳市海王生 物工程股份有限公司独立董事，深圳市雄韬电源科技股份有限公司独立董事，深 圳市格灵人工智能与机器人研究院有限公司董事长，深圳市深迹新技术有限公司 执行董事，深圳君盛润石天使创业投资合伙企业(有限合伙)投决会委员，深圳市 华瀛管理咨询有限公司执行董事。 （二）独立性说明 深圳市杰恩创意设计股份有限公司 2024年度独立董事述职报告（张华） 公司董事会、各位股东及股东代表： 本人作为深圳市杰恩创意设计股份有限公司（以下简称"公司"）的独立董 事，严格按照《公司法》《证券法》《深圳证券交易所创业板股票上市规则》《深 ...

经核查独立董事古继洪先生、武国樑先生、杨骏晟先生的任职经历以及签 署的相关自查文件，上述人员及其配偶、父母、子女、主要社会关系未在公司 或公司附属企业担任除独立董事以外的任何职务，也未在公司主要股东公司及 其附属企业担任任何职务，与公司以及主要股东之间不存在利害关系或其他可 能妨碍其进行独立客观判断的关系，不存在影响独立董事独立性的情况，符合 《上市公司独立董事管理办法》《深圳证券交易所创业板股票上市规则》《深 圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》中 对独立董事独立性的相关要求。 深圳市杰恩创意设计股份有限公司 董事会 2025 年 4 月 22 日 深圳市杰恩创意设计股份有限公司 董事会关于独立董事独立性自查情况的专项报告 深圳市杰恩创意设计股份有限公司（以下简称"公司"）董事会根据《上 市公司独立董事管理办法》《深圳证券交易所创业板股票上市规则》《深圳证 券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》《公司 章程》及《独立董事工作制度》等相关法律法规、规章制度的规定，就公司在 任独立董事古继洪先生、武国樑先生、杨骏晟先生的独立性情况进行评估并出 具如下 ...

Revenue and Profitability - The company's revenue for Q1 2025 was ¥88,791,347.67, a decrease of 10.13% compared to ¥98,804,690.04 in the same period last year[5] - The net loss attributable to shareholders was ¥1,619,788.89, an improvement of 81.84% from a loss of ¥8,921,732.74 in the previous year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥3,252,886.35, a decrease of 68.76% compared to -¥10,412,782.78 last year[5] - Net profit attributable to the parent company was -¥1,619,788.89, compared to -¥8,921,732.74 in the previous period, showing an improvement of approximately 81.8%[21] - The company achieved a basic earnings per share of -¥0.0135, improving from -¥0.0741 in the previous period[22] Cash Flow and Liquidity - The net cash flow from operating activities was ¥35,532,901.72, a significant increase of 179.83% compared to -¥44,507,971.44 in the same period last year[10] - The company reported a net cash flow from operating activities of ¥35,532,901.72, a significant recovery from -¥44,507,971.44 in the previous period[23] - Cash received from operating activities increased significantly to ¥180,699,423.41 from ¥113,797,593.31, an increase of approximately 58.8%[23] - Net cash flow from investment activities was $29,880,826.08, a significant improvement compared to a negative cash flow of $5,746,853.85 in the previous period[24] - Total cash and cash equivalents at the end of the period increased to $205,428,382.61 from $157,696,307.17, reflecting a net increase of $30,864,316.78[24] - Cash outflow from financing activities totaled $34,496,869.17, compared to an inflow of $27,883,056.66 in the previous period, indicating a shift in financing strategy[24] - Cash inflow from financing activities was $30,000,000.00, primarily from borrowings[24] - Cash outflow for investment activities was $110,606,242.41, down from $163,505,106.46, showing a reduction in capital expenditures[24] - The company reported a cash flow impact from foreign exchange fluctuations of -$52,541.85, indicating some exposure to currency risk[24] Assets and Liabilities - The company's total assets decreased by 6.11% to ¥1,098,668,348.18 from ¥1,170,201,607.57 at the end of the previous year[5] - The total liabilities decreased from ¥400,702,170.29 to ¥331,920,432.12, a reduction of about 17.2%[18] - The total liabilities decreased to ¥357,141,623.73 from ¥427,037,082.18, a reduction of approximately 16.3%[22] - The company has a total asset value of ¥1,098,668,348.18, down from ¥1,170,201,607.57, indicating a decrease of approximately 6.13%[18] - Total current assets decreased from ¥981,839,496.48 to ¥913,246,591.94, reflecting a decline of approximately 6.96%[18] Shareholder Information - The total number of common shareholders at the end of the reporting period is 5,287[13] - The largest shareholder, Guangdong Jinsheng Xinkang Investment Center, holds 25.06% of shares, totaling 30,167,800 shares[13] Research and Development - Research and development expenses were reduced by 68.92% to ¥1,239,846.67 from ¥3,989,667.97 in the same period last year[9] - Research and development expenses decreased to ¥1,239,846.67 from ¥3,989,667.97, a decline of about 68.9% year-over-year[21] Other Financial Metrics - The weighted average return on equity improved to -0.22% from -1.15% year-on-year[5] - The company recorded a credit impairment loss of ¥10,341,915.96, compared to a loss of -¥2,029,228.11 in the previous period[21] - Other income decreased by 76.98% to ¥256,384.53 from ¥1,113,660.21 in the previous year, primarily due to a reduction in government subsidies received[9] - The company has a total of 49,561,888.20 in other receivables, slightly up from 47,769,538.21[17] - The company’s accounts receivable decreased from ¥600,068,169.21 to ¥533,971,192.25, a decline of approximately 11.06%[17] - The company’s total non-current assets decreased from ¥188,362,111.09 to ¥185,421,756.24, a reduction of about 1.03%[18] Audit and Accounting Standards - The company did not undergo an audit for the first quarter report, which may affect investor confidence in the reported figures[25] - The company has not yet adopted the new accounting standards that will take effect in 2025, which could impact future financial reporting[25]

Financial Performance - The company reported total operating revenue of 585.92 million yuan, a decrease of 21.74% compared to the previous year[4]. - The net profit attributable to shareholders was -11.99 million yuan, representing a decline of 120.91% year-on-year[4]. - The company's operating revenue for 2024 was ¥585,924,773.75, a decrease of 21.74% compared to ¥748,689,390.03 in 2023[22]. - The net profit attributable to shareholders for 2024 was -¥11,995,500.85, representing a decline of 120.91% from ¥57,374,073.82 in 2023[22]. - The net cash flow from operating activities was -¥35,940,963.52 in 2024, a significant drop of 1,219.89% compared to -¥2,723,021.00 in 2023[22]. - The total assets at the end of 2024 amounted to ¥1,170,201,607.57, a decrease of 0.73% from ¥1,178,780,410.91 at the end of 2023[22]. - The company's basic earnings per share for 2024 was -¥0.10, down 120.83% from ¥0.48 in 2023[22]. - The weighted average return on equity was -1.59% for 2024, down from 7.64% in 2023[22]. - The net profit after deducting non-recurring gains and losses for 2024 was -¥16,348,780.29, a decline of 131.54% from ¥51,832,495.28 in 2023[22]. Revenue Sources - Revenue from market business and service support was ¥365,851,846.52, accounting for 62.44% of total revenue, down 19.50% from the previous year[61]. - Revenue from interior design was ¥208,584,227.93, which is 35.60% of total revenue, reflecting a decline of 25.48% year-over-year[61]. Market Conditions and Challenges - The decline in revenue was primarily due to a reduction in new signed orders in the interior design segment, influenced by industry cyclical adjustments and intensified competition[4]. - The overall performance of the vaccine industry also impacted the company's business and service support operations[4]. - The company has faced uncertainty regarding its ability to continue as a going concern, as indicated by the negative net profits over the last three accounting years[22]. - The company is facing dual challenges in its main business segments, with a decline in new contract amounts in the design business and a drop in performance in the market business and service support[53]. - The company is experiencing intensified market competition in the business support services sector, which may further escalate as market dynamics evolve[111]. Strategic Initiatives and Future Plans - The company plans not to distribute cash dividends or issue bonus shares[5]. - Future plans and strategic developments mentioned do not constitute profit forecasts or commitments to investors[4]. - The company is focusing on addressing management risks associated with scale expansion and talent management[5]. - The company aims to enhance public awareness of vaccines to strengthen its market position in the non-immunization planning vaccine sector[38]. - The company is focusing on channel expansion in key regions through enhanced collaboration with distributors to meet vaccine demand[56]. - The company is committed to ongoing R&D investments to drive digital transformation and improve core competitiveness[57]. Governance and Compliance - The company’s legal representatives and accounting personnel have confirmed the accuracy and completeness of the financial report[4]. - The company has implemented a comprehensive governance structure, revising multiple internal regulations to ensure compliance and protect shareholder interests[60]. - The company has established a fair and transparent performance evaluation and incentive mechanism for senior management[127]. - The company maintains independence from its controlling shareholders in terms of assets, personnel, finance, and operations[129]. Risks and Uncertainties - The report highlights potential risks including policy risks, accounts receivable recovery risks, and intensified market competition[5]. - The company acknowledges the risk of research and development failures, which could hinder future performance if initial investments do not yield expected benefits[115]. - There is a risk of accounts receivable collection issues as the company expands, which could adversely affect its financial condition if clients face significant operational challenges[110]. Employee and Talent Management - The total number of employees at the end of the reporting period is 749, with 448 in the parent company and 301 in major subsidiaries[169]. - The company has established a competitive salary incentive management system linked to employee performance and company performance[170]. - The company aims to optimize its talent development strategy, enhancing employee engagement and performance through improved incentive mechanisms and performance evaluations[107]. Research and Development - The company has established a flexible and efficient joint innovation platform with several universities to strengthen its R&D capabilities[51]. - The company is developing an AI assistant focused on interior design to enhance the professional knowledge of new designers and improve work efficiency[70]. - The company’s R&D investment amounted to ¥21,223,397.64 in 2024, representing 3.62% of operating revenue, a decrease from 3.83% in 2023[75]. Shareholder Engagement - The annual general meeting had a participation rate of 31.32% on May 17, 2024[136]. - The company approved a cash dividend of RMB 3.00 per 10 shares, totaling RMB 36,114,381.90 (including tax) based on a total share capital of 120,381,273 shares as of December 31, 2023[173]. - The company’s profit distribution plan aligns with its articles of association and relevant regulations[174]. Social Responsibility and Sustainability - The company actively engages in social responsibility, focusing on sustainable development and customer value[198]. - The company plans to invest 75 million in sustainability initiatives over the next three years to align with environmental goals[139].

登录新浪财经APP 搜索【信披】查看更多考评等级 三、投资风险及风险控制措施 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗 漏。 深圳市杰恩创意设计股份有限公司（以下简称"公司"）于2024年8月28日召开第三届董事会第二十次会 议、第三届监事会第十五次会议，2024年9月18日召开2024年第一次临时股东大会，审议通过了《关于 使用闲置自有资金进行现金管理的议案》，同意公司使用不超过人民币15,000万元的闲置自有资金进行 现金管理。该事项自公司股东大会审议通过之日起12个月内有效，在决议有效期间可循环滚动使用额 度。具体内容详见公司于2024年8月29日、2024年9月18日在巨潮资讯网（http://www.cninfo.com.cn）披 露的相关公告。 近期，公司使用闲置自有资金购买了理财产品，现就相关事宜公告如下： 一、本次购买理财产品的基本情况 ■ 注：公司与上述理财产品受托方均无关联关系，本次使用闲置自有资金进行现金管理不会构成关联交 易。 二、审批程序 《关于使用闲置自有资金进行现金管理的议案》已分别经第三届董事会第二十次会议、第三届监事会第 十五 ...

证券代码：300668 证券简称：杰恩设计 公告编号：2025-018 注：公司与上述理财产品受托方均无关联关系，本次使用闲置自有资金进行 现金管理不会构成关联交易。 二、审批程序 《关于使用闲置自有资金进行现金管理的议案》已分别经第三届董事会第 深圳市杰恩创意设计股份有限公司 关于使用闲置自有资金进行现金管理的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 深圳市杰恩创意设计股份有限公司（以下简称"公司"）于 2024 年 8 月 28 日召开第三届董事会第二十次会议、第三届监事会第十五次会议，2024 年 9 月 18 日召开 2024 年第一次临时股东大会，审议通过了《关于使用闲置自有资金进 行现金管理的议案》，同意公司使用不超过人民币 15,000 万元的闲置自有资金 进行现金管理。该事项自公司股东大会审议通过之日起 12 个月内有效，在决议 有效期间可循环滚动使用额度。具体内容详见公司于 2024 年 8 月 29 日、2024 年 9 月 18 日在巨潮资讯网（http://www.cninfo.com.cn）披露的相关公告。 近期，公司 ...

近期，公司使用闲置自有资金购买了理财产品，现就相关事宜公告如下： 证券代码：300668 证券简称：杰恩设计 公告编号：2025-017 深圳市杰恩创意设计股份有限公司 关于使用闲置自有资金进行现金管理的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 深圳市杰恩创意设计股份有限公司（以下简称"公司"）于 2024 年 8 月 28 日召开第三届董事会第二十次会议、第三届监事会第十五次会议，2024 年 9 月 18 日召开 2024 年第一次临时股东大会，审议通过了《关于使用闲置自有资金进 行现金管理的议案》，同意公司使用不超过人民币 15,000 万元的闲置自有资金 进行现金管理。该事项自公司股东大会审议通过之日起 12 个月内有效，在决议 有效期间可循环滚动使用额度。具体内容详见公司于 2024 年 8 月 29 日、2024 年 9 月 18 日在巨潮资讯网（http://www.cninfo.com.cn）披露的相关公告。 | 受托 | 产品名称 | 金额 （万 | 起息日 | 到期日 | 产品 | 预期年化 | | 资 金 | | --- ...

证券代码：300668 证券简称：杰恩设计 公告编号：2025-016 特此公告。 深圳市杰恩创意设计股份有限公司 董事会 深圳市杰恩创意设计股份有限公司 关于独立董事取得独立董事培训证明的公告 2025 年 3 月 13 日 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 深圳市杰恩创意设计股份有限公司（以下简称"公司"）于 2025 年 1 月 3 日召 开 2025 年第一次临时股东大会，审议通过了《关于董事会换届选举第四届董事会独立 董事的议案》，选举古继洪先生、武国樑先生、杨骏晟先生为公司第四届董事会独立 董事，任期自公司 2025 年第一次临时股东大会审议通过之日起三年。 因截至公司 2025 年第一次临时股东大会通知发出之日，古继洪先生、武国樑先 生、杨骏晟先生尚未取得深圳证券交易所认可的相关培训证明，根据深圳证券交易所 的有关规定，古继洪先生、武国樑先生、杨骏晟先生书面承诺参加最近一次独立董事 培训并取得深圳证券交易所认可的独立董事资格证书。具体内容详见公司于 2024 年 12 月 19 日在巨潮资讯网（http://www.cninfo.c ...

现场检查报告 华泰联合证券有限责任公司 关于深圳市杰恩创意设计股份有限公司 2024年现场检查报告 根据中国证监会《证券发行上市保荐业务管理办法》和《深圳证券交易所上市公 司自律监管指引第 13 号——保荐业务》等有关法律法规的要求，华泰联合证券有限责 任公司作为深圳市杰恩创意设计股份有限公司（以下简称"杰恩设计"或"公司"）2020 年度向特定对象发行股票的保荐人，于 2025 年 2 月 21 日对深圳市杰恩创意设计股份 有限公司 2024 年有关情况进行了现场检查，报告如下： | 保荐人名称：华泰联合证券有限责任公司 被保荐公司简称：杰恩设计 | | | | | --- | --- | --- | --- | | 保荐代表人姓名：贾光宇 联系电话：755-81902000 | | | | | 保荐代表人姓名：滕强 联系电话：755-81902000 | | | | | 现场检查人员姓名：贾光宇、胡轶聪 | | | | | 现场检查对应期间：2024 年度 | | | | | 现场检查时间：2025 年 2 月 21 日 | | | | | 一、现场检查事项 | | 现场检查意见 | | | （一）公司治 ...